Search

Purpose: Current research has not extensively explored the correlation between Systemic Inflammatory Index (SII) and prostate-specific antibody (PSA) levels. This study aimed to investigate the relationship between the SII and PSA levels in American males aged > 40 years without prostate cancer. Methods: Data were obtained from the 2003–2010 National Health and Nutrition Examination Survey (NHANES). Patients without complete SII or PSA data were excluded. Multiple linear regression models were used to investigate the possibility of a linear association between the SII and PSA levels. Fitted smoothed curves and threshold effect analyses were used to characterize the nonlinear relationships. Results: The study included 5982 male participants over the age of 40 years from the United States. The average SII (mean ± standard deviation) was 562.78 ± 355.60. The mean value of PSA was 1.85 ± 3.24. The results showed that SII exhibited a positive correlation with PSA (β = 0.0005, 95% CI: (0.0002, 0.0007)), and an interaction test indicated that the effects of age, body mass index, hypertension, and diabetes were not significant for this positive correlation between SII and PSA (all P > 0.05). We discovered an inverted U-shaped connection between the SII and PSA with a turning point (K) of 1168.18 by using a two-segment linear regression model. To the left of the turning point, there was a positive connection between SII and PSA (β = 0.0009,95% CI: (0.0006, 0.0012); P < 0.0001). Conclusion: In the population of men over 40 years old without prostate cancer, SII and PSA exhibited a non-linear relationship. Specifically, there was a positive correlation between SII and PSA levels when the SII value was < 1168.18. [ABSTRACT FROM AUTHOR]

The article "Enhancing Adherence to Health Behaviors Research: Reflections on Current Methods and Future Directions" by Tang, Zeng, and Tang discusses a study on the relationship between mindfulness, perceived health competence, and health behavior adherence in patients with acute coronary syndrome. The authors raise concerns about the methodology used in the study, suggesting that multiple regression analysis would provide more accurate results and that further analysis on subgroups such as age and gender is necessary for a comprehensive understanding. They emphasize the importance of psychological and behavioral interventions in improving health outcomes and call for more personalized interventions in the future. [Extracted from the article]

The letter published in the Clinical Interventions in Aging journal discusses the importance of inflammatory markers in predicting clinical outcomes in elderly patients with acute ischemic stroke (AIS). The authors highlight the need for including baseline neurological function assessments, statistical tests to confirm the combined use of NLR and LMR, and separate analysis of neutrophil count in predicting prognosis. The study by Wang et al provides valuable insights for future research and clinical practice in understanding the role of inflammatory factors in AIS prognosis. [Extracted from the article]

The taste of blue honeysuckle (Lonicera caerulea L.) berries is wrapped in bitterness, and awareness about the essence of bitterness is lacking. In the current study, 7-ketologanin, sweroside and loganin were isolated and identified as key bitter compounds using sensory-guided analysis. The bitterness thresholds of these compounds were determined to be 11.9 μg/mL, 33.5 μg/mL and 60.2 μg/mL. Subsequently, the differences in bitterness among 16 blue honeysuckle varieties were evaluated. The wild varieties A1 and A2 exhibited the highest bitter intensity. 7-Ketologanin, with the highest concentration of 34.70–37.11 mg/100 g and taste activity values of 29.16–31.18 in A1 and A2, was first identified as a bitter contributor in blue honeysuckle. There was no significant difference in bitter intensity between the reconstitution model and the original sample, confirming the contribution of the three bitter compounds. This study lays the foundation for the bitter improvement and variety selection of blue honeysuckle resources. [Display omitted] • There were 32 potential bitter compounds identified in blue honeysuckle berries. • 7-Ketologanin was firstly identified in blue honeysuckle berries. • 7-Ketologanin, sweroside and loganin were determined as the key bitter compounds. • The threshold values of 3 bitter compounds in water were firstly determined. • Bitter differences were explored among 16 blue honeysuckle varieties. [ABSTRACT FROM AUTHOR]